GL1X · GenesisL1 explorer

MolNFT v1 · #132471 · protein

Pandda analysis group deposition -- AAR2/RNASEH in complex with fragment F2X-entry C08, dmso-free

5R0C · Pre-mRNA-splicing factor 8: “Pandda analysis group deposition -- AAR2/RNASEH in complex with fragment F2X-entry C08, dmso-free”. X-ray diffraction, 1 ligand (R8V), 7 pockets (best druggability 0.48). MolNFT v1 #132471 on GenesisL1…

PDB
5R0C
Type
protein
Length
537 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pre-mRNA-splicing factor 8; A1 cistron-splicing factor AAR2
UniProt
P33334, P32357
Ligands
R8V
Pockets
7 · best druggability 0.48

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APre-mRNA-splicing factor 8protein23747% helix, 19% strandP33334
BA1 cistron-splicing factor AAR2protein30045% helix, 17% strandP32357

Ligands and binding sites

  • R8V · (3S)-3-hydroxy-2-methyl-2,3-dihydro-1H-isoindol-1-one · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1550.480.8512empty
22320.470.7337empty
31290.440.7617empty
4890.420.7818empty
5550.380.8011R8V

Interfaces

1 interface between chains.

  • A–B · 477 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 5R0C · PanDDA analysis group deposition -- Aar2/RNaseH in complex with fragment F2X-Entry C08… · the same entry in another collection · chain A against A, TM-score 1.00
  • P32357 · AlphaFold monomer V2.0 prediction for A1 cistron-splicing factor AAR2 (P32357) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.